LabConnect to Showcase Innovative Ambient Sample Shipping System at DIA
Logistics can be one of the most complex aspects of successful clinical trials because samples shipped from study sites for testing at a central laboratory may come with very limited temperature range requirements. LabConnect, an innovative provider of central laboratory solutions, will be demonstrating how its Snuggy Clinical Kit, an ambient specimen shipping system, reduces weight and logistical costs and saves investigative sites valuable time and storage space at the Drug Information Association (DIA) annual meeting.
“Logistics can account for as much as 40 percent of the total cost of a clinical trial, and large bulky shippers are a huge irritant to sites,” said LabConnect President and CEO Eric Hayashi. “Validated cold-chain solutions are expensive, so controlled ambient shipping solutions like the Snuggy Clinical Kit are becoming increasingly important in PBMC and other analyses where high cellular viability and yields are critical.”
The Snuggy Clinical Kit was initially custom-designed for a two-year clinical study of progressive multiple sclerosis.
“We set out to develop a compact shipping system to save sites space and save our clients money while maintaining the test tubes within a very limited target temperature range,” Hayashi said. In multiple tests exposing the Snuggy Clinical Kit to extreme heat and cold, temperature variability remained well within the client’s requirements.
“When our custom kits are combined with our vast network of local laboratories around the world, shipping distances are reduced; therefore, significant savings in logistics are possible,” Hayashi said.
In addition to custom kit-building, LabConnect’s services to the biopharmaceutical industry include routine and specialized testing, biostorage and scientific operations support services utilizing advanced data management and reporting systems. To see a demonstration of the Snuggy Clinical Kit, an ambient specimen shipping system, visit LabConnect in booth #616 at DIA.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
